Traxis Partners’s Zimmer Biomet ZBH Stock Holding History

Traxis Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-30,900	Closed	-$2.25M	–	35
2013 Q2	$2.25M	Buy	+30,900	New	+$2.31M	1.74%	27

Other funds holding ZBH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Traxis Partners's ZBH Position: Q3 2013 in Review

Traxis Partners sold out of Zimmer Biomet (ZBH) in Q3 2013, closing a stake of 30,900 shares — an estimated $2.25M sold.

Traxis Partners first reported a position in ZBH in Q2 2013 and held it in 1 quarter. The position peaked at $2.25M in Q2 2013. 650 funds tracked by Wall St. Rank hold ZBH as of Q3 2013.

Traxis Partners reported no remaining Zimmer Biomet position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 30,900 Zimmer Biomet shares in Q3 2013, an estimated $2.25M.
Traxis Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 1 quarter.
Traxis Partners's Zimmer Biomet position peaked at $2.25M in Q2 2013.
650 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.